Table 1. Clinical characteristics and biochemical characteristics of PF in study population (n=98).
| Characteristics | Pleural TB group (n=55) | No pleural TB Group (n=43) | P Value |
|---|---|---|---|
| Age, median (range), yrs | 39(25-59,) | 57(47-67) | 0.003 |
| Gender(female/male,) | 18/37 | 18/25 | 0.200 |
| BCG scar | 5 | 4 | 1.000 |
| Complications | |||
| Diabetes mellitus | 9 | 7 | 0.991 |
| ADA, U/L | 48.15(35.63-66.43) | 12.35(8.9-16.73) | 0.000 |
| Lymphocyte, /μl | 2124(1285-3342) | 965(615.25-2153.5) | 0.018 |
| Rivalta test * , (n) | 36/9 | 37/5 | 0.305 |
| Albumin, mg/dl | 47.20(41.40-52.45) | 46.10(37.43-51.93)- | 0.165 |
| LDH, IU/L | 282.4(186.6-565.2) | 367.10(261.38-584.25) | 0.912 |
| CRP, mg/ml | 16.04(5.41-26.63) | 4.79(2.24-17.40) | 0.018 |
| Cause of effusion | Microbiology (n=28) | Malignant PF (n=35) | |
| Histopathology (n=27) | Parapneumonia effusion (n=4) | ||
| Autoimmune disease (n=3) | |||
| pulmonary embolism(n=1) |
Abbreviations: TB, tuberculosis; ADA, adenosine deaminase; LDH, lactate dehydrogenase; CRP, C reactive protein.
* Rivalta test: is used as a puncture fluid test for differentiation of exudate and transudate.